70 related articles for article (PubMed ID: 24674778)
41. Platelet-rich plasma and chronic wounds: remaining fibronectin may influence matrix remodeling and regeneration success.
Moroz A; Deffune E
Cytotherapy; 2013 Nov; 15(11):1436-9. PubMed ID: 23993645
[TBL] [Abstract][Full Text] [Related]
42. Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of mandibular degree II furcation defects: a randomized controlled clinical trial.
Bajaj P; Pradeep AR; Agarwal E; Rao NS; Naik SB; Priyanka N; Kalra N
J Periodontal Res; 2013 Oct; 48(5):573-81. PubMed ID: 23317096
[TBL] [Abstract][Full Text] [Related]
43. A comparative study of 2 methods for obtaining platelet-rich plasma.
Tamimi FM; Montalvo S; Tresguerres I; Blanco Jerez L
J Oral Maxillofac Surg; 2007 Jun; 65(6):1084-93. PubMed ID: 17517290
[TBL] [Abstract][Full Text] [Related]
44. Pooled platelet concentrates and the quality of the red blood cell supply.
Zimmermann R; Weiss DR; Zingsem J; Ringwald J; Eckstein R
Clin Lab; 2012; 58(1-2):1-6. PubMed ID: 22372340
[No Abstract] [Full Text] [Related]
45. Effect of preoperative subcutaneous platelet-rich plasma and fibrin glue application on skin flap survival.
Findikcioglu F; Findikcioglu K; Yavuzer R; Lortlar N; Atabay K
Aesthetic Plast Surg; 2012 Oct; 36(5):1246-53. PubMed ID: 22890863
[TBL] [Abstract][Full Text] [Related]
46. The potential use of allogeneic platelet-rich plasma for large bone defect treatment: immunogenicity and defect healing efficacy.
Zhang ZY; Huang AW; Fan JJ; Wei K; Jin D; Chen B; Li D; Bi L; Wang J; Pei G
Cell Transplant; 2013; 22(1):175-87. PubMed ID: 22863146
[TBL] [Abstract][Full Text] [Related]
47. The effect of platelet-rich plasma on osteoblast and periodontal ligament cell migration, proliferation and differentiation.
Creeper F; Lichanska AM; Marshall RI; Seymour GJ; Ivanovski S
J Periodontal Res; 2009 Apr; 44(2):258-65. PubMed ID: 19210334
[TBL] [Abstract][Full Text] [Related]
48. [Methods of preparation of the platelet-rich plasma used in medicine as an accelerator of tissue regeneration].
Kesy L; Kopczyński P; Baszczuk A; Kopczyński Z
Pol Merkur Lekarski; 2014 Apr; 36(214):283-6. PubMed ID: 24868905
[TBL] [Abstract][Full Text] [Related]
49. Comment on "Platelet-Rich Plasma as a novel therapeutic agent in osteomyelitis".
Jia W; Zhang C
Med Hypotheses; 2009 Aug; 73(2):270-1. PubMed ID: 19321269
[No Abstract] [Full Text] [Related]
50. By the way, doctor. Last August you wrote about platelet-rich plasma therapy for chronic tendon problems. Has there been any news since then? I ask because I'm thinking about it for my tennis elbow.
Robb-Nicholson C
Harv Womens Health Watch; 2010 Jun; 17(10):8. PubMed ID: 20687237
[No Abstract] [Full Text] [Related]
51. [The use of platelet rich plasma in treatment of chronic inflammation of bones].
Szypuła J; Kedziora J
Pol Merkur Lekarski; 2009 Aug; 27(158):132-5. PubMed ID: 19856880
[TBL] [Abstract][Full Text] [Related]
52. A New Regulatory Framework for Platelet-Rich Plasma in Spain.
Anitua E; Prado R; Orive G
J Knee Surg; 2015 Aug; 28(4):355-6. PubMed ID: 25927353
[No Abstract] [Full Text] [Related]
53. [Blood transfusion].
Uchiyama T
Rinsho Byori; 2011 Feb; Suppl 147():147-51. PubMed ID: 21766525
[No Abstract] [Full Text] [Related]
54. [Can I continue to use platelet-rich-plasma on my patients? How do I use it legally?].
Fernández Santos ME
Rev Esp Cir Ortop Traumatol; 2014; 58(2):65-7. PubMed ID: 24674778
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
